Sigmund — a friendly Freud mascot seated in a green armchair, holding a notepad and a cigar.

The intelligence scribe for psychiatry

Sigmund

A scribe that knows psychiatry.

Sigmund writes the note. Captures the MSE. Cites the evidence. Built for psychiatrists. Validated at 87.4% accuracy.

Built at

The gap

The evidence exists. It doesn't reach the patient.

12.9%

of U.S. children with ADHD receive any medication. The AAP, AACAP, and FDA publish concordant treatment guidelines. 60–70% of pediatric ADHD cases in community settings are managed off-guideline — not because the evidence doesn't exist, but because no system delivers it to the right decision at the right moment.

Generic AI sounds clinical, but it can't tell a methylphenidate trial in adults from one in preschoolers. Sigmund can.

A glimpse of Sigmund at work

The analyst, working.

An auto-playing demonstration of how Sigmund reasons about a real patient case. The voice is character-driven; the clinical content is real.

Sigmund mascot
listening
Auto-playing · synthesized audio · no patient data

How Sigmund works for you

Built for the work. Cited by default. Signed by you.

Built for the work.

Abridge captures the conversation. Sigmund captures the conversation, the MSE, and the risk assessment.

Cited by default.

Every recommendation arrives with the PMIDs. Click any line. See the studies behind it.

You sign every note.

The signature line stays empty. The MSE stays editable. The clinician closes the loop.

Time back where it matters.

Freed users report 30 minutes saved per clinic day. Sigmund matches that — with the citations.

Validation

Deployed. Validated. Endorsed.

Generation 1 of Sigmund (the CEBA-ADHD engine) has been operating at Integrative Psychiatry Manhattan, a high-volume outpatient child psychiatry practice in New York City.

87.4%

Diagnostic accuracy across five condition categories

100%

Clinical staff endorsement of improved work quality

400%

Increase in documentation volume per encounter

0

Patient safety complaints across the deployment

N = 124 charts · Integrative Psychiatry Manhattan · effect sizes r = 0.81–0.88 versus generic AI baselines.

In the note

Drafting a real case.

An 8-year-old boy. ADHD with anxiety comorbidity. No prior treatment. As Sigmund drafts the note, it ranks the treatment options the clinician will document — by what the evidence supports:

Pt: Pediatric · ID 4471 · 8 y · M Visit · 2026-05-08 · 14:32

History of Present Illness

Eight-year-old male presents with a nine-month history of inattention and academic decline. Mother reports difficulty completing schoolwork, frequent fidgeting, and new-onset evening anxiety with episodic refusal to attend school. No prior psychiatric treatment. No family history of stimulant use or substance use disorder.¹

Mental Status Exam

Appearance
Well-groomed, age-appropriate
Behavior
Cooperative; mild psychomotor fidgeting
Speech
Normal rate, rhythm, volume
Mood / Affect
"Okay" / euthymic, mildly anxious; congruent
Thought process
Linear, goal-directed
Thought content
No SI / HI / AVH
Insight / Judgment
Age-appropriate

Assessment

ADHD, combined presentation (F90.2) with comorbid generalized anxiety disorder (F41.1). Treatment-naive. Acuity: routine.

Plan

  • Initiate evidence-based behavioral parent training, weekly × 8 sessions.¹
  • Defer stimulant trial pending behavioral response; per AACAP 2019, first-line for comorbid anxiety profile.²
  • Reassess at 4 weeks. If anxiety persists or behavioral response is partial, consider atomoxetine before methylphenidate.³
  • Patient and parent education materials provided. Follow-up scheduled.
¹AACAP Practice Parameter for the Assessment and Treatment of Children and Adolescents with ADHD, §3.1 · 2019
²Pelham et al. · Sequencing of psychosocial and pharmacologic treatments for ADHD · RCT N=152 · PMID 27567456
³Atomoxetine in pediatric ADHD with comorbid anxiety · meta-analysis · 14 RCTs · PMID 31204870

The note arrives as a draft. The MSE, the differential, the citation chain — all surfaced by Sigmund. The clinician edits, signs, and finalizes.

How it works

Five vectors. Section by section. Citation by citation.

Generic clinical AI collapses every paper into a single fuzzy "topic match." Sigmund splits each paper into five section-level vectors — and ranks treatments against the patient profile across every dimension at once.

Overview
0.62
Population
0.94
Intervention
0.81
Outcomes
0.89
Timing
0.76

Combined with evidence-tier weighting (RCT > meta-analysis > cohort), recency boosts, and effect-size aggregation, the result is a citation-traceable treatment ranking. No black box.

Traceable, always

Every recommendation, traceable to the evidence.

Click any recommendation. The PMIDs unfold. Study design, sample size, effect size, year. The full evidence trail behind every ranking.

Atomoxetine · score 0.935 · rank #2 for this profile

PMID 28723456 Atomoxetine in pediatric ADHD with comorbid anxiety: a randomized controlled trial RCT · N=176 · 2017
PMID 31204870 Comparative effectiveness of non-stimulants in pediatric ADHD-anxiety comorbidity Meta-analysis · 14 RCTs · 2019
PMID 35402189 Long-term atomoxetine safety profile in children aged 6–12: pooled analysis Cohort · N=2,084 · 2022
AACAP §3.1 Practice Parameter for the Assessment and Treatment of Children and Adolescents with ADHD Guideline · 2019

Where the work happens

In the chart. Where the clinician already is.

Sigmund lives where clinicians already work. Voice-activated. Chart-embedded. Background-operating. The system adapts to the clinician, not the other way around.

Patient: [Pediatric · ID 4471] Visit · 2026-05-08 · 14:32
Age / Sex8 y · M
Chief complaintInattention, school behavioral concerns, evening anxiety.
Prior treatmentNone.
ComorbiditiesGeneralized anxiety, mild.
Sigmund: Three options ranked. Behavioral intervention first. Atomoxetine elevated for the anxiety. Methylphenidate flagged — may worsen the anxiety. Want the evidence chain?
"Show me the evidence for atomoxetine." — voice command active

Built to integrate with

Epic·Athena·Practice Fusion·ICANotes·Tebra

Integration active for design-partner clinics. Broader EHR rollout follows the private beta.

In your day

What changes when Sigmund is in the room.

Concrete daily wins. No more pajamas-and-charting at midnight.

Your last note finishes before your last visit ends.

Sigmund drafts as you talk. The note arrives in your inbox when the door closes behind the patient — not at 11 PM.

Your MSE writes itself.

Not a checkbox list. A real mental status exam, in your clinical voice, ready to sign.

Your prior-auth fights, halved.

Every clinical claim arrives with the citation that justifies it. Notes that go to payers read like the textbook.

Your patient gets your full attention.

No keyboard. No screen. Sigmund listens so you don't have to type.

Backed by NIH-funded research at the Sultan Lab · Columbia · NYSPI.

The roadmap

One architecture. Many engines.

Sigmund's multi-vector architecture is condition-agnostic. ADHD is the index condition because the longitudinal evidence infrastructure exists today. The rest follow the same architecture.

ADHD

Generation 1 deployed at Integrative Psychiatry Manhattan. Validated. R21 pending.

Anxiety

Next engine. Largest pediatric and adult literature base. Natural extension of multi-vector architecture.

Depression

Builds on the population-derived risk framework from the R01.

Comorbidity

ASD-ADHD, anxiety-depression. The architecture was built for this from day one.

About

Built by clinicians, for clinicians.

Ryan Sultan, MD

Ryan Sultan, MD

Assistant Professor of Clinical Psychiatry, Columbia University Irving Medical Center · Attending Psychiatrist, NewYork-Presbyterian · Director, Sultan Lab for Mental Health Informatics.

Double board-certified in Adult and Child/Adolescent Psychiatry. NIH NIDA K12 awardee. Forty-plus peer-reviewed publications including landmark work in JAMA Psychiatry, JAMA Network Open (440+ citations), and Pediatrics. The 2019 JAMA Network Open study on antipsychotic prescribing in youth is taught in psychiatry residency programs nationally. The 2025 JAMA Psychiatry analysis showed ADHD medication reduces criminal convictions, substance-related ED visits, and motor vehicle crashes by 30–42%.

Sigmund is built from a deeply held conviction: the gap between what the evidence supports and what reaches the patient is a solvable problem.

See the mentors and collaborators behind this work →

Engineered for safety

Quaternary-level data protection.

Patient privacy is a structure. Sigmund is engineered like one — four layers, each reinforcing the next.

HIPAA compliant.

Built from day one to the HIPAA Privacy and Security Rules. Business Associate Agreement signed with every clinic.

US-only data.

Compute, storage, and inference inside US borders. Patient data never leaves the country.

Encrypted end-to-end.

AES-256 at rest. TLS 1.3 in transit. Audit-logged on every access. No exceptions.

Your data trains nothing.

Not OpenAI. Not Anthropic. Not us. Your charts power your clinic — and only your clinic.

Sigmund is investigational and intended to assist — not replace — clinical judgment. Patient data handling reviewed by the Sultan Lab for Mental Health Informatics at Columbia University Irving Medical Center.

Common questions

What you'll want to know.

What does it cost?

Sigmund is in private beta with founding clinicians. Pricing is being finalized for the public launch in Q3 2026 — expect a per-clinician monthly subscription competitive with leading psychiatric AI tools. Founding clinicians receive a permanent discount.

Will it work with my EHR?

Yes. Sigmund is built to read from and write to Epic, Athena, Practice Fusion, ICANotes, and Tebra. Integration is active for design-partner clinics; broader EHR rollout follows the private beta. If your EHR isn't listed, tell us in the waitlist form and we'll prioritize.

What if I leave Sigmund?

Your notes are yours. Export to PDF or structured JSON at any time, in bulk. We don't lock data; we keep it portable by design.

Does it handle telehealth visits?

Yes. Sigmund captures the visit whether the patient is across the room or across the country. Same MSE precision, same citation chain, same auditability.

Who is responsible for the clinical content of the note?

You. Sigmund drafts; the clinician signs. The signature line stays empty until you complete it. Sigmund is decision support — never a decision-maker.

Private beta · Founding clinician pricing

Be the first clinician to deploy Sigmund.

We're rolling out access to a small group of psychiatrists this quarter. Tell us about your practice — we'll be in touch within a week. Public pricing announced Q3 2026.

We collect your email solely to contact you about early access. No marketing lists. No third parties.

Thank you.

We'll be in touch. In the meantime, take a look at the science.

Join waitlist →